Semin Respir Crit Care Med 2008; 29(3): 271-284
DOI: 10.1055/s-2008-1076747
© Thieme Medical Publishers

Lung Cancer: Preoperative Pulmonary Evaluation of the Lung Resection Candidate

Hataya Poonyagariyagorn1 , Peter J. Mazzone1
  • 1Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio
Further Information

Publication History

Publication Date:
02 June 2008 (online)

ABSTRACT

Lung resection provides the best chance of cure for individuals with early-stage non-small-cell lung cancer. Lung resection will lead to a decrease in lung function. The population that develops lung cancer often has concomitant lung disease and a reduced ability to tolerate further losses in lung function. The goal of the preoperative pulmonary assessment of individuals with resectable lung cancer is to identify those individuals whose short- and long-term morbidity and mortality would be unacceptably high if surgical resection were to occur. Pulmonary function measures such as the forced expiratory volume in 1 second (FEV1) and the diffusing capacity for carbon monoxide (DLCO) are useful predictors of postoperative outcome. When lung function in not normal, the prediction of postoperative lung function from preoperative results, and the assessment of exercise capacity, can help to clarify the risks. Testing algorithms and published guidelines help to direct the order of testing. Interventions that allow us to consider resection outside of the guidelines, or to maximize the potential to tolerate lung resection, help us to offer potentially curative treatment to as many as possible. Knowledge of alternative treatment options will help to guide those deemed unfit for resection.

REFERENCES

  • 1 Evans E WT. Resection for bronchial carcinoma in the elderly.  Thorax. 1973;  28 86-88
  • 2 Nou E. The natural five-year course in bronchial carcinoma: epidemiologic results.  Cancer. 1984;  53 2211-2216
  • 3 Sobue T, Suzuki T, Matsuda M et al.. Survival for clinical stage I lung cancer not surgically treated: comparison between screen-detected and symptom-detected cases. The Japanese Lung Cancer Screening Research Group.  Cancer. 1992;  69 685-692
  • 4 Motohiro A, Ueda H, Komatsu H et al.. Prognosis of non-surgically treated, clinical stage I lung cancer patients in Japan.  Lung Cancer. 2002;  36 65-69
  • 5 Sato M, Saito Y, Endo C et al.. The natural history of radiographically occult bronchogenic squamous cell carcinoma: a retrospective study of overdiagnosis bias.  Chest. 2004;  126 108-113
  • 6 Loewen G M, Watson D, Kohman L et al.. Preoperative exercise VO2 measurement for lung resection candidates: results of Cancer and Leukemia Group B protocol 9238.  J Thorac Oncol. 2007;  2 619-625
  • 7 Damhuis R AM, Schutte P R. Resection rates and postoperative mortality in 7,899 patients with lung cancer.  Eur Respir J. 1996;  9 7-10
  • 8 Harpole D H, Liptay M J, DeCamp M M et al.. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias.  Ann Thorac Surg. 1996;  61 977-982
  • 9 Deslauriers J, Ginsberg R J, Piantadosi S, Fournier B. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer.  Chest. 1994;  106 329S-330S
  • 10 Dales R E, Dionne G, Leech J A et al.. Preoperative prediction of pulmonary complications following thoracic surgery.  Chest. 1993;  104 155-159
  • 11 Duque J L, Ramos G, Castrodeza J et al.. Early complications in surgical treatment of lung cancer: a prospective, multicenter study.  Ann Thorac Surg. 1997;  63 944-950
  • 12 Little A G, Rusch V W, Bonner J A et al.. Patterns of surgical care of lung cancer patients.  Ann Thorac Surg. 2005;  80 2051-2056
  • 13 Allen M S, Darling G E, Pechet T V et al.. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.  Ann Thorac Surg. 2006;  81 1013-1020
  • 14 The International Early Lung Cancer Action Program Investigators . Survival of patients with stage I lung cancer detected on CT screening.  N Engl J Med. 2006;  355 1763-1771
  • 15 Baser S, Shannon V R, Eapen G A et al.. Pulmonary dysfunction as a major cause of inoperability among patients with non-small-cell lung cancer.  Clin Lung Cancer. 2006;  7 344-349
  • 16 Schussler O, Alifano M, Dermine H et al.. Postoperative pneumonia after major lung resection.  Am J Respir Crit Care Med. 2006;  173 1161-1169
  • 17 Bolliger C T, Jordan P, Soler M et al.. Pulmonary function and exercise capacity after lung resection.  Eur Respir J. 1996;  9 415-421
  • 18 Nezu K, Kushibe K, Tojo T, Takahama M, Kitamura S. Recovery and limitation of exercise capacity after lung resection for lung cancer.  Chest. 1998;  113 1511-1516
  • 19 Takizawa T, Haga M, Yagi N et al.. Pulmonary function after segmentectomy for small peripheral carcinoma of the lung.  J Thorac Cardiovasc Surg. 1999;  118 536-541
  • 20 Boushy S F, Billig D M, North L B, Helgason A H. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma.  Chest. 1971;  59 383-391
  • 21 Edwards J G, Duthie D JR, Waller D A. Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema.  Thorax. 2001;  56 791-795
  • 22 Bobbio A, Chetta A, Carbognani P et al.. Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection.  Eur J Cardiothorac Surg. 2005;  28 754-758
  • 23 Brown J S, Eraut D, Trask C, Davison A G. Age and the treatment of lung cancer.  Thorax. 1996;  51 564-568
  • 24 Kirsh M M, Rotman H, Bove E et al.. Major pulmonary resection for bronchogenic carcinoma in the elderly.  Ann Thorac Surg. 1976;  22 369-373
  • 25 Breyer R H, Zippe C, Pharr W F et al.. Thoracotomy in patients over age seventy years: ten-year experience.  J Thorac Cardiovasc Surg. 1981;  81 187-193
  • 26 Nagasaki F, Flehinger B J, Martini N. Complications of surgery in the treatment of carcinoma of the lung.  Chest. 1982;  82 25-29
  • 27 Ginsberg R J, Hill L D, Eagan R T et al.. Modern thirty-day operative mortality for surgical resections in lung cancer.  J Thorac Cardiovasc Surg. 1983;  86 654-658
  • 28 Sherman S, Guidot C E. The feasibility of thoracotomy for lung cancer in the elderly.  JAMA. 1987;  258 927-930
  • 29 Ishida T, Yokoyama H, Kaneko S et al.. Long-term results of operation for non-small-cell lung cancer in the elderly.  Ann Thorac Surg. 1990;  50 919-922
  • 30 Shirakusa T, Tsutsui M, Iriki N et al.. Results of resection for bronchogenic carcinoma in patients over the age 80.  Thorax. 1989;  44 189-191
  • 31 Roxburgh J C, Thompson J, Goldstraw P. Hospital mortality and long-term survival after pulmonary resection in the elderly.  Ann Thorac Surg. 1991;  51 800-803
  • 32 Riquet M, Manac'h D, Le Pimpec-Barthes F et al.. Operation for lung cancer in the elderly: what about octogenarians?.  Ann Thorac Surg. 1994;  58 916
  • 33 Massard G, Moog R, Wihlm J M et al.. Bronchogenic cancer in the elderly: operative risk and long-term prognosis.  Thorac Cardiovasc Surg. 1996;  44 40-45
  • 34 Pagni S, Federico J A, Ponn R B. Pulmonary resection for lung cancer in octogenarians.  Ann Thorac Surg. 1997;  63 785-789
  • 35 Port J L, Kent M, Korst R J et al.. Surgical resection for lung cancer in the octogenarian.  Chest. 2004;  126 733-738
  • 36 Zeiher B G, Gross T J, Kern J A et al.. Predicting postoperative pulmonary function in patients undergoing lung resection.  Chest. 1995;  108 68-72
  • 37 Nakahara K, Monden Y, Ohno K et al.. A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer.  Ann Thorac Surg. 1985;  39 260-265
  • 38 Kristersson S, Lindell S E, Svanberg L. Prediction of pulmonary function loss due to pneumonectomy using 133Xe-radiospirometry.  Chest. 1972;  62 694-698
  • 39 Bria W F, Kanarek D J, Kazemi H. Prediction of postoperative pulmonary function following thoracic operations: value of ventilation-perfusion scanning.  J Thorac Cardiovasc Surg. 1983;  86 186-192
  • 40 Ali M K, Mountain C F, Ewer M S et al.. Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma.  Chest. 1980;  77 337-342
  • 41 Corris P A, Ellis D A, Hawkins T, Gibson G J. Use of radionuclide scanning in the preoperative estimation of pulmonary function after pneumonectomy.  Thorax. 1987;  42 285-291
  • 42 Ladurie M LR, Ranson-Bitker B. Uncertainties in the expected value for forced expiratory volume in one second after surgery.  Chest. 1986;  90 222-228
  • 43 Giordano A, Calcagni M L, Meduri G et al.. Perfusion lung scintigraphy for the prediction of postlobectomy residual pulmonary function.  Chest. 1997;  111 1542-1547
  • 44 Wu M T, Chang J M, Chiagn A A et al.. Use of quantitative CT to predict postoperative lung function in patients with lung cancer.  Radiology. 1994;  191 257-262
  • 45 Wu M T, Pan H B, Chiang A A et al.. Prediction of postoperative lung function in patients with lung cancer: comparison of quantitative CT with perfusion scintigraphy.  AJR Am J Roentgenol. 2002;  178 667-672
  • 46 Sverzellati N, Chetta A, Calabro E et al.. Reliability of quantitative computed tomography to predict postoperative lung function in patients with chronic obstructive pulmonary disease having a lobectomy.  J Comput Assist Tomogr. 2005;  29 819-824
  • 47 Ueda K, Kaneda Y, Sudoh M et al.. Role of quantitative CT in predicting hypoxemia and complications after lung lobectomy for cancer, with special reference to area of emphysema.  Chest. 2005;  128 3500-3506
  • 48 Licker M J, Widdiker I, Robert J et al.. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends.  Ann Thorac Surg. 2006;  81 1830-1838
  • 49 Kearney D J, Lee T H, Reilly J J et al.. Assessment of operative risk in patients undergoing lung resection: importance of predicted pulmonary function.  Chest. 1994;  105 753-759
  • 50 Mitsudomi T, Mizoue T, Yoshimatsu T et al.. Postoperative complications after pneumonectomy for treatment of lung cancer: multivariate analysis.  J Surg Oncol. 1996;  61 218-222
  • 51 Ribas J, Diaz O, Barbera J A et al.. Invasive exercise testing in the evaluation of patients at high-risk for lung resection.  Eur Respir J. 1998;  12 1429-1435
  • 52 Nakahara K, Ohno K, Hashimoto J et al.. Prediction of postoperative respiratory failure in patients undergoing lung resection for lung cancer.  Ann Thorac Surg. 1988;  46 549-552
  • 53 Brunelli A, Fianchini A. Predicted postoperative FEV1 and complications in lung resection candidates.  Chest. 1997;  111 1145-1146
  • 54 Putnam J B, Lammermeier D E, Colon R et al.. Predicted pulmonary function and survival after pneumonectomy for primary lung carcinoma.  Ann Thorac Surg. 1990;  49 909-915
  • 55 Wahi R, McMurtrey M J, DeCaro L F et al.. Determinants of perioperative morbidity and mortality after pneumonectomy.  Ann Thorac Surg. 1989;  48 33-37
  • 56 Markos J, Mullan B P, Hillman D R et al.. Preoperative assessment as a predictor of mortality and morbidity after lung resection.  Am Rev Respir Dis. 1989;  139 902-910
  • 57 Boysen P G, Block A J, Olsen G N et al.. Prospective evaluation for pneumonectomy using the 99mTechnetium quantitative perfusion lung scan.  Chest. 1977;  72 422-425
  • 58 Boysen P G, Harris J O, Block A J, Olsen G N. Prospective evaluation of pneumonectomy using perfusion scanning: follow-up beyond one year.  Chest. 1981;  80 163-166
  • 59 Wernly J A, DeMeester T R, Kirchner P T et al.. Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma.  J Thorac Cardiovasc Surg. 1980;  80 535-543
  • 60 Ferguson M K, Little L, Rizzo L et al.. Diffusing capacity predicts morbidity and mortality after pulmonary resection.  J Thorac Cardiovasc Surg. 1988;  96 894-900
  • 61 Wang J, Olak J, Ultmann R E, Ferguson M K. Assessment of pulmonary complications after lung resection.  Ann Thorac Surg. 1999;  67 1444-1447
  • 62 Bousamra M, Presberg K W, Chammas J H et al.. Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity.  Ann Thorac Surg. 1996;  62 968-975
  • 63 Ferguson M K, Reeder L B, Mick R. Optimizing selection of patients for major lung resection.  J Thorac Cardiovasc Surg. 1995;  109 275-283
  • 64 Pierce R J, Copland J M, Sharpe K, Barter C E. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality.  Am J Respir Crit Care Med. 1994;  150 947-955
  • 65 Morice R C, Peters E J, Ryan M B et al.. Exercise testing in the evaluation of patients at high risk for complications from lung resection.  Chest. 1992;  101 356-361
  • 66 Walsh G L, Morice R C, Putnam J B et al.. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption.  Ann Thorac Surg. 1994;  58 704-711
  • 67 Pate P, Tenholder M F, Griffin J P et al.. Preoperative assessment of the high-risk patient for lung resection.  Ann Thorac Surg. 1996;  61 1494-1500
  • 68 Olsen G N, Weiman D S, Bolton J WR et al.. Submaximal invasive exercise testing and quantitative lung scanning in the evaluation for tolerance of lung resection.  Chest. 1989;  95 267-273
  • 69 Bolliger C T, Wyser C, Roser H et al.. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications.  Chest. 1995;  108 341-348
  • 70 Bolliger C T, Jordan P, Soler M et al.. Exercise capacity as a predictor of postoperative complications in lung resection candidates.  Am J Respir Crit Care Med. 1995;  151 1472-1480
  • 71 Richter Larsen K, Svendsen U G, Milman N, Brenøe J, Petersen B N. Exercise testing in the preoperative evaluation of patients with bronchogenic carcinoma.  Eur Respir J. 1997;  10 1559-1565
  • 72 Brutsche M H, Spiliopoulos A, Bolliger C T et al.. Exercise capacity and extent of resection as predictors of surgical risk in lung cancer.  Eur Respir J. 2000;  15 828-832
  • 73 Win T, Jackson A, Sharples L et al.. Cardiopulmonary exercise tests and lung cancer surgical outcome.  Chest. 2005;  127 1159-1165
  • 74 Smith T P, Kinasewitz G T, Tucker W Y et al.. Exercise capacity as a predictor of post-thoracotomy morbidity.  Am Rev Respir Dis. 1984;  129 730-734
  • 75 Bechard D, Wetstein L. Assessment of exercise oxygen consumption as preoperative criterion for lung resection.  Ann Thorac Surg. 1987;  44 344-349
  • 76 Nakagawa K, Nakahara K, Miyoshi S, Kawashima Y. Oxygen transport during incremental exercise load as a predictor of operative risk in lung cancer patients.  Chest. 1992;  101 1369-1375
  • 77 Wang J S, Abboud R T, Evans K G et al.. Role of CO diffusing capacity during exercise in the preoperative evaluation for lung resection.  Am J Respir Crit Care Med. 2000;  162 1435-1444
  • 78 Rao V, Todd T RJ, Kuus A et al.. Exercise oximetry versus spirometry in the assessment of risk prior to lung resection.  Ann Thorac Surg. 1995;  60 603-609
  • 79 Ninan M, Sommers K E, Landreneau R J et al.. Standardized exercise oximetry predicts postpneumonectomy outcome.  Ann Thorac Surg. 1997;  64 328-333
  • 80 Win T, Jackson A, Groves A M et al.. Relationship of shuttle walk test and lung cancer surgical outcome.  Eur J Cardiothorac Surg. 2004;  26 1216-1219
  • 81 Bolton J WR, Weiman D S, Haynes J L et al.. Stair climbing as an indicator of pulmonary function.  Chest. 1987;  92 783-788
  • 82 Pollock M, Roa J, Benditt J, Celli B. Estimation of ventilatory reserve by stair climbing: a study in patients with chronic airflow obstruction.  Chest. 1993;  104 1378-1383
  • 83 Olsen G N, Bolton J WR, Weiman D S, Hornung C A. Stair climbing as an exercise test to predict the postoperative complications of lung resection: two years' experience.  Chest. 1991;  99 587-590
  • 84 Holden D A, Rice T W, Stelmach K, Meeker D P. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection.  Chest. 1992;  102 1774-1779
  • 85 Brunelli A, Al Refai M, Monteverde M et al.. Stair climbing test predicts cardiopulmonary complications after lung resection.  Chest. 2002;  121 1106-1110
  • 86 Brunelli A, Sabbatini A, Xiume F et al.. Inability to perform maximal stair climbing test before lung resection: a propensity score analysis on early outcome.  Eur J Cardiothorac Surg. 2005;  27 367-372
  • 87 Singh S J, Morgan M DL, Scott S et al.. Development of a shuttle walking test of disability in patients with chronic airways obstruction.  Thorax. 1992;  47 1019-1024
  • 88 Singh S J, Morgan M DL, Hardman A E et al.. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation.  Eur Respir J. 1994;  7 2016-2020
  • 89 Olsen G N, Block A J, Swenson E W et al.. Pulmonary function evaluation of the lung resection candidate: a prospective study.  Am Rev Respir Dis. 1975;  111 379-387
  • 90 Miller J I. Physiologic evaluation of pulmonary function in the candidate for lung resection.  J Thorac Cardiovasc Surg. 1993;  105 347-352
  • 91 Wyser C, Stulz P, Soler M et al.. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates.  Am J Respir Crit Care Med. 1999;  159 1450-1456
  • 92 Turna A, Mercan C A, Bedirhan M A. Prediction of morbidity after lung resection in patients with lung cancer using fuzzy logic.  Thorac Cardiovasc Surg. 2005;  53 368-374
  • 93 Geddes D, Davies M, Koyama H et al.. Effect of lung-volume-reduction surgery in patients with severe emphysema.  N Engl J Med. 2000;  343 239-245
  • 94 National Emphysema Treatment Trial Research Group . Patients at high risk of death after lung-volume-reduction surgery.  N Engl J Med. 2001;  345 1075-1083
  • 95 National Emphysema Treatment Trial Research Group . A randomized trial comparing lung volume-reduction surgery with medical therapy for severe emphysema.  N Engl J Med. 2003;  348 2059-2073
  • 96 Choong C K, Meyers B F, Battafarano R J et al.. Lung cancer resection combined with lung volume reduction in patients with severe emphysema.  J Thorac Cardiovasc Surg. 2004;  127 1323-1331
  • 97 DeRose J J, Argenziano M, El-Amir N et al.. Lung reduction operation and resection of pulmonary nodules in patients with severe emphysema.  Ann Thorac Surg. 1998;  65 314-318
  • 98 DeMeester S R, Patterson G A, Sundaresan R S, Cooper J D. Lobectomy combined with volume reduction for patients with lung cancer and advanced emphysema.  J Thorac Cardiovasc Surg. 1998;  115 681-688
  • 99 Ojo T C, Martinez F, Paine R et al.. Lung volume reduction surgery alters management of pulmonary nodules in patients with severe COPD.  Chest. 1997;  112 1494-1500
  • 100 McKenna R J, Fischel R J, Brenner M, Gelb A F. Combined operations for lung volume reduction surgery and lung cancer.  Chest. 1996;  110 885-888
  • 101 British Thoracic Society and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party . Guidelines on the selection of patients with lung cancer for surgery.  Thorax. 2001;  56 89-108
  • 102 Colice G L, Shafazand S, Griffin J P, Keenan R, Bolliger C T. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery.  Chest. 2007;  132 161-177
  • 103 Lung Cancer Study Group . Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer.  Ann Thorac Surg. 1995;  60 615-623
  • 104 Iizasa T, Suzuki M, Yasufuku K et al.. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.  Ann Thorac Surg. 2004;  77 1896-1902 discussion 1902-1903
  • 105 Mery C M, Pappas A N, Bueno R et al.. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database.  Chest. 2005;  128 237-245
  • 106 Okada M, Nishio W, Sakamoto T et al.. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.  J Thorac Cardiovasc Surg. 2005;  129 87-93
  • 107 El-Sherif A, Gooding W E, Santos R et al.. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.  Ann Thorac Surg. 2006;  82 408-416
  • 108 Ghosh S, Sujendran V, Alexiou C, Beggs L, Beggs D. Long term results of surgery versus continuous hyperfractionated accelerated radiotherapy (CHART) in patients aged > 70 years with stage I non-small cell lung cancer.  Eur J Cardiothorac Surg. 2003;  24 1002-1007
  • 109 Landreneau R J, Sugarbaker D J, Mack M J et al.. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer.  J Thorac Cardiovasc Surg. 1997;  113 691-698 discussion 698-700
  • 110 Yoshida J, Nagai K, Yokose T et al.. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience.  J Thorac Cardiovasc Surg. 2005;  129 991-996
  • 111 Linden P A, Bueno R, Colson Y L et al.. Lung resection in patients with preoperative FEV1 < 35% predicted.  Chest. 2005;  127 1984-1990
  • 112 Koizumi K, Haraguchi S, Hirata T et al.. Surgical treatment for lung cancer patients with poor pulmonary function.  Ann Thorac Cardiovasc Surg. 2005;  11 87-92
  • 113 Keenan R J, Landreneau R J, Maley R H et al.. Segmental resection spares pulmonary function in patients with stage I lung cancer.  Ann Thorac Surg. 2004;  78 228-233
  • 114 Nugent A M, Steele I C, Carragher A M et al.. Effect of thoracotomy and lung resection on exercise capacity in patients with lung cancer.  Thorax. 1999;  54 334-338
  • 115 Shennib H, Bogart J, Herndon J E et al.. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study.  J Thorac Cardiovasc Surg. 2005;  129 813-818
  • 116 Goldstein N S, Ferkowicz M, Kestin L, Chmielewski G W, Welsh R J. Wedge resection margin distances and residual adenocarcinoma in lobectomy specimens.  Am J Clin Pathol. 2003;  120 720-724
  • 117 Birdas T J, Koehler R PM, Colonias A et al.. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer.  Ann Thorac Surg. 2006;  81 434-439
  • 118 Bach P B, Cramer L D, Schrag D, Downey R J, Gelfand S E, Begg C B. The influence of hospital volume on survival after resection for lung cancer.  N Engl J Med. 2001;  345 181-188
  • 119 Warner M A, Divertie M B, Tinker J H. Preoperative cessation of smoking and pulmonary complications in coronary artery bypass patients.  Anesthesiology. 1984;  60 380-383
  • 120 Bluman L G, Mosca L, Newman N, Simon D G. Preoperative smoking habits and postoperative pulmonary complications.  Chest. 1998;  113 883-889
  • 121 Vaporciyan A A, Merriman K W, Ece F et al.. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation.  Ann Thorac Surg. 2002;  73 420-426
  • 122 Barrera R, Shi W, Amar D et al.. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy.  Chest. 2005;  127 1977-1983
  • 123 Dresler C M, Bailey M, Roper C R, Patterson A, Cooper J D. Smoking cessation and lung resection.  Chest. 1996;  110 1199-1202
  • 124 Mitsuta K, Shimoda T, Fukushima C et al.. Preoperative steroid therapy inhibits cytokine production in the lung parenchyma in asthmatic patients.  Chest. 2001;  120 1175-1183
  • 125 Hirata T, Ogawa E, Takenaka K, Kawashita F. Suppression of postoperative systemic inflammatory response syndrome with clarithromycin following lung cancer surgery.  Eur Surg Res. 2004;  36 13-19
  • 126 Weiner P, Man A, Weiner M et al.. The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection.  J Thorac Cardiovasc Surg. 1997;  113 552-557
  • 127 Algar F J, Alvarez A, Salvatierra A, Baamonde C, Aranda J L, Lopez-Pujol F J. Predicting pulmonary complications after pneumonectomy for lung cancer.  Eur J Cardiothorac Surg. 2003;  23 201-208
  • 128 Aguilo R, Togores B, Pons S, Rubi M, Barbe F, Agusti A GN. Noninvasive ventilatory support after lung resectional surgery.  Chest. 1997;  112 117-121
  • 129 Cesario A, Ferri L, Galetta D et al.. Pre-operative pulmonary rehabilitation and surgery for lung cancer.  Lung Cancer. 2007;  57 118-119
  • 130 Spruit M A, Janssen P P, Willemsen S CP, Hochstenbag M MH, Wouters E FM. Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: A pilot study.  Lung Cancer. 2006;  52 257-260
  • 131 Cesario A, Ferri L, Galetta D et al.. Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer.  Lung Cancer. 2007;  57 175-180
  • 132 Timmerman R D, Park C, Kavanagh B D. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer.  J Thorac Oncol. 2007;  2(S3) S101-S112
  • 133 Song D Y, Kavanagh B D, Benedict S H, Schefter T. Stereotactic body radiation therapy: rationale, techniques, applications, and optimization.  Oncology. 2004;  18 1419-1430
  • 134 Xia T, Li H, Sun Q et al.. Promising clinical outcome of stereotactic body radiotherapy for patients with inoperable stage I/II non-small cell lung cancer.  Int J Radiat Oncol Biol Phys. 2006;  66 117-125
  • 135 Onishi H, Kuriyama K, Komiyama T et al.. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.  Lung Cancer. 2004;  45 45-55
  • 136 Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.  Int J Radiat Oncol Biol Phys. 2004;  60 186-196
  • 137 Timmerman R, Papiez L, McGarry R et al.. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.  Chest. 2003;  124 1946-1955
  • 138 Nguyen C L, Scott W J, Goldberg M. Radiofrequency ablation of lung malignancies.  Ann Thorac Surg. 2006;  82 365-371
  • 139 de Baere T, Palussiere J, Auperin A et al.. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.  Radiology. 2006;  240 587-596
  • 140 Ambrogi M C, Lucchi M, Dini P et al.. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term.  Eur J Cardiothorac Surg. 2006;  30 177-183
  • 141 Fernando H C, De Hoyos A, Landreneau R J et al.. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.  J Thorac Cardiovasc Surg. 2005;  129 639-644
  • 142 Lagana D, Carrafiello G, Mangini M et al.. Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device.  Surg Endosc. 2006;  20 1262-1267
  • 143 Nguyen C L, Scott W J, Young N A, Rader T, Giles L R, Goldberg M. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study.  Chest. 2005;  128 3507-3511

Peter J MazzoneM.D. 

Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

9500 Euclid Ave., A90, Cleveland, OH 44195

Email: mazzonp@ccf.org

    >